Teva Pharmaceutical Industries Limited (TEVA)
After hours:
| Previous close | 17.38 |
| Open | 17.45 |
| Bid | 17.35 x 4000 |
| Ask | 17.52 x 1100 |
| Day's range | 17.27 - 17.62 |
| 52-week range | 8.06 - 19.08 |
| Volume | |
| Avg. volume | 8,288,368 |
| Market cap | 19.885B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.39 |
| Earnings date | 06 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Nov 2017 |
| 1y target est | 21.14 |
GlobeNewswireTeva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate
The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024The collaboration supports Teva's Pivot to Growth strategy and adds to the company’s biosimilar portfolio Both companies reaffirm their shared commitment to making high-quality, affordable treatments accessible to patients worldwide TEL AVIV, ISRAEL and MADRID, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceut
- GlobeNewswire
Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.
This first-to-market launch showcases Teva’s proven strengths in complex generic formulations and enhances Teva’s strategic goal of sustaining a generic powerhouse.Octreotide acetate for injectable suspension is indicated to treat acromegaly and severe diarrhea for carcinoid syndrome. PARSIPPANY, N.J., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of the first and only generic vers
Insider MonkeyWhy Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?
We recently compiled a list of the 8 Best Stocks Under $50 To Invest In Now. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against the other stocks under $50. As we navigate through 2024, the economic landscape presents a mix of challenges and opportunities for […]